Lorazepam and diazepam effects on memory acquisition in priming tasks. 1994

P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
Département de Psychiatrie, Hôpitaux Universitaires, Strasbourg, France.

Unlike diazepam, lorazepam has repeatedly been shown to impair perceptual priming as well as explicit memory. To determine whether this deleterious effect was due to an impairment in acquisition of information, 60 healthy volunteers were randomly assigned to five treatment groups (placebo, lorazepam 0.026 or 0.038 mg/kg, diazepam 0.2 or 0.3 mg/kg) and successively performed perceptual priming tasks and a free-recall task. Priming performance on information learned before or 2 h after drug administration, i.e. at the peak concentration of lorazepam, was assessed under the influence of the drugs, using a picture-fragment and a word-stem completion task. Free-recall performance was altered by both drugs. Lorazepam decreased priming performance when information was acquired after, but not before, drug administration, indicating that the drug alters the acquisition of information. Lorazepam also impaired the ability to identify fragmented pictures, but there was no evidence that this perceptual effect accounts for the priming impairment. Surprisingly, diazepam also decreased priming when information was acquired after drug administration, suggesting that, at least in certain circumstances, the two benzodiazepines may exert similar effects on priming measures.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D007858 Learning Relatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge. Phenomenography
D008140 Lorazepam A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. Apo-Lorazepam,Ativan,Donix,Duralozam,Durazolam,Idalprem,Laubeel,Lorazep Von Ct,Lorazepam Medical,Lorazepam-Neuraxpharm,Lorazepam-Ratiopharm,Novo-Lorazem,Nu-Loraz,Orfidal Wyeth,Sedicepan,Sinestron,Somagerol,Temesta,Tolid,Témesta,WY-4036,Apo Lorazepam,Lorazepam Neuraxpharm,Lorazepam Ratiopharm,Medical, Lorazepam,Novo Lorazem,Nu Loraz,Von Ct, Lorazep,WY 4036,WY4036,Wyeth, Orfidal
D008297 Male Males
D008606 Mental Processes Conceptual functions or thinking in all its forms. Information Processing, Human,Human Information Processing
D011939 Mental Recall The process whereby a representation of past experience is elicited. Recall, Mental
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
January 1987, European journal of clinical pharmacology,
P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
January 1992, Psychopharmacology,
P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
December 1983, The Journal of clinical psychiatry,
P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
February 1984, Pharmacology, biochemistry, and behavior,
P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
October 1998, Hormones and behavior,
P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
January 1993, International clinical psychopharmacology,
P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
August 2001, Vision research,
P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
April 1978, Experientia,
P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
January 1990, Psychopharmacology,
P Vidailhet, and J M Danion, and F Kauffmann-Muller, and D Grangé, and A Giersch, and M van der Linden, and J L Imbs
January 1992, Psychopharmacology,
Copied contents to your clipboard!